Global mobility Global mobility We are a global company with a global outlook. We welcome the breadth of perspective that international experience brings to our teams.
RE-LY-trial-publication-10-year-anniversary RE-LY-trial-publication-10-year-anniversary Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
FDA accepts new chronic kidney disease treatment application FDA accepts new chronic kidney disease treatment application FDA accepts new chronic kidney disease treatment application
antibiotic resistance one health veterinary medicine antibiotic resistance one health veterinary medicine Antimicrobial resistance is a major global threat to the health of humans and animals alike. Learn about challenges and solutions here.
Collaboration Boehringer Ingelheim Veeva technology Collaboration Boehringer Ingelheim Veeva technology Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Equestrian sports horse health awareness Alex Hua Tian Equestrian sports horse health awareness Alex Hua Tian Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.
Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies
FDA Grants Breakthrough Status to Schizophrenia Treatment FDA Grants Breakthrough Status to Schizophrenia Treatment Boehringer Ingelheim and Click Therapeutics receive FDA Breakthrough Device Designation for schizophrenia prescription digital therapeutic
Martin Stefanic Martin Stefanic Martin Stefanic, Patient Safety Therapeutic Area Head for Oncology, discusses his move to Patient Safety.
Winners of BVDzero Scholarship Programme Winners of BVDzero Scholarship Programme Boehringer Ingelheim announces winners of BVDzero Scholarship Programme
Henke-Sass Wolf develop needle free device Henke-Sass Wolf develop needle free device Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
New vaccine against Bovine Respiratory Disease New vaccine against Bovine Respiratory Disease Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.
New production center for Veterinary Public Health New production center for Veterinary Public Health Boehringer Ingelheim invests more than €200 million to establish a strategic production center for Veterinary Public Health in Lyon, France.
Official partner to Cat Care for Life Official partner to Cat Care for Life Boehringer Ingelheim announces its new partnership with the CatCareforLife program.
Making-more-health-together-2021 Making-more-health-together-2021 1,200 participants from around the world join virtual convention on November 11-12
FDA approves Jardiance treatment chronic kidney disease FDA approves Jardiance treatment chronic kidney disease U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease
Partnership African animal trypanosomiasis Partnership African animal trypanosomiasis New partnership working on solutions to combat African animal trypanosomiasis
Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reports a strong performance in 2022.
Lead with Pride – for the Benefit of All. Lead with Pride – for the Benefit of All. How Inclusive Leadership advocates for Acceptance and creating a Sense of Belonging
Odile Bain Memorial Prize 2021 Odile Bain Memorial Prize 2021 Brilliant early-career scientists in parasitology recognized
2018 Animal Welfare Medals 2018 Animal Welfare Medals 2018 Animal Welfare Medals: Boehringer Ingelheim recognizes outstanding research in cattle, equine, swine, as well as small animals and pet categories
environmental sustainability commitments environmental sustainability commitments On the occasion of the 2021 UN Climate Change Conference (COP26), Boehringer Ingelheim shares an update on its strategic approach to sustainability
Combating food insecurity for more health equity in the U.S. Combating food insecurity for more health equity in the U.S. Meet social innovation founder Katie at Making More Health Together 2023: How the social innovation founder brings fresh food stores back to the U.S.
New cancer therapeutics collaboration with 3T Bio New cancer therapeutics collaboration with 3T Bio Boehringer Ingelheim and 3T Biosciences collaborate to discover and develop next-generation cancer therapies to address high unmet patient needs
Partnership with Precision Health Research, Singapore Partnership with Precision Health Research, Singapore Boehringer Ingelheim joins forces with Precision Health Research, Singapore with the aim of transforming healthcare and improving patient outcomes in Singapore and beyond.